BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Omeros Corporation (OMER) Release: OMS721 Inhibits Thrombus Formation In Sera from aHUS Patients 11/19/2014 12:32:36 PM
Omeros Corporation (OMER) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:46 AM
Omeros Corporation (OMER) Announces Positive Data for MASP-2 Inhibitor In Experimental Model Of Stroke 11/6/2014 6:20:26 AM
Omeros Corporation (OMER) To Announce Third Quarter 2014 Financial Results On November 10, 2014 11/4/2014 8:49:34 AM
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014 8:14:36 AM
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014 5:41:25 AM
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:47 AM
Omeros Corporation (OMER) To Present At The Wedbush Pacgrow 2014 Life Sciences Management Access Conference 8/8/2014 8:40:36 AM
Omeros Corporation (OMER) Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures 6/2/2014 6:49:25 AM
Omeros Corporation (OMER) Reports First Quarter 2014 Financial Results 5/13/2014 6:26:46 AM
12345678910...